FUHRMANN ULRIKE
No ORCID on file
· 450 papers in corpus
· active 2006-2011
Frequent coauthors
- SCHMIDT ANJA 432
- MOELLER CARSTEN 432
- SCHWEDE WOLFGANG 270
- SCHMEES NORBERT 162
- KAUFMANN-REICHE ULRIKE 144
- BOTHE ULRICH 144
- ROTGERI ANDREA 126
- KIRKLAND THOMAS ANDREW 108
- HILLISCH ALEXANDER 72
- DROESCHER PETER 72
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
2011
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…